Actinium Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Actinium Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2013 to Q3 2024.
  • Actinium Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 31.1M shares, a 14.8% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 26.6M shares, a 10.2% increase from 2022.
  • Actinium Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 24.1M shares, a 17.4% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 31.1M +4.01M +14.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 30.1M +3.89M +14.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 27.9M +2.19M +8.52% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 26.6M +2.46M +10.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 27.1M +1.89M +7.53% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 26.2M +2.49M +10.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 25.7M +3.55M +16% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 24.1M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 25.2M +3.63M +16.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 23.7M +3.5M +17.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 22.1M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 21.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 20.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q3 2016 47.7M +6.48M +15.8% Jul 1, 2016 Sep 30, 2016 10-Q 2016-10-28
Q2 2016 46.5M +9.82M +26.8% Apr 1, 2016 Jun 30, 2016 10-Q 2016-07-29
Q3 2015 41.2M Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 36.7M +10.9M +42.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q2 2014 25.8M +3.62M +16.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q2 2013 22.2M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.